China India Israel covid-19 China India Israel

Israel approves import of generic of AbbVie’s HIV drug for Covid-19

Reading now: 546
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Israel health ministry has approved the licensing of a generic version of AbbVie’s HIV drug Kaletra to treat Covid-19, as the cases in the country exceed 500.

The patent for the anti-viral drug Kaletra expires in Israel in 2024, while the patent in other countries, including India, already expired.

Israel attorney general for the first time allowed the use of a generic version of a patent-protected drug, noted Reuters. To protect the patent, the generic medication, imported from countries where patent expired, will not be given to HIV patients but only be used for treating the novel coronavirus infection.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA